Biogen announces they are "branching out" from MS drugs like tysabri and looking at blood disorders and other neurological diseases. hmmmm.....


Biogen to build blood disorder drug franchise
www.reuters.com
BOSTON (Reuters) - Biogen Idec Inc, which makes the multiple sclerosis drugs Tysabri and Avonex, plans to build a portfolio of products to treat noncancerous blood disorders, according to its chief executive.The